首页> 中文期刊> 《中国社区医师》 >角膜基质内注射氟康唑治疗真菌性角膜炎的疗效分析

角膜基质内注射氟康唑治疗真菌性角膜炎的疗效分析

         

摘要

目的:探讨角膜基质内注射氟康唑治疗真菌性角膜炎的临床价值。方法:2013年10月-2014年10月收治真菌性角膜炎患者57例,对所有患者给予角膜基质内注射氟康唑治疗,分析其治疗效果。结果:本组57例患者中,治愈42例(73.68%),好转13例(22.81%),无效2例(3.51%),临床治疗总有效率96.49%。无一例患者出现角膜切口感染。注射以后没有明显刺激症状和疼痛,无一例患者出现角膜内皮失代偿。临床住院时间6~30 d,平均(14.2±6.8)d。结论:真菌性角膜炎采取角膜基质内注射氟康唑治疗,可以有效促进溃疡愈合,使住院时间明显缩短,具有临床推广价值。%Objective:To investigate the application value of fluconazol injection in coneal stroma in the treatment of fungal keratitis.Methods:57 patients with fungal keratitis were selected from October 2013 to October 2014.All the patients were given fluconazol injection in coneal stroma,and analyzed the therapeutic effect.Results:In 57 patients in this study,there 42 cases were cured(73.68%);13 cases were improved(22.81%);2 cases were invalid(3.51%),the total efficiency was 96.49%.There was none case occured corneal incision infection.Without obviously irritation and pain after the injection,and also had none of the patients with corneal endothelial decompensation.The hospitalization time was 6~30 days,and averaged(14.2 ± 6.8) days.Conclusion:Fluconazol injection in coneal stroma use in fungal keratitis can promote the healing of ulcer effectively,and shorten the hospitalization time obviously,so it has value to be spread in clinical.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号